| titleOfInvention |
Eszopiclone and trans 4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine or trans 4- (3,4-dichlorophenyl) -1,2,3 4-Tetrahydro-1-naphthalenamine combinations and methods for treating menopause and mood, anxiety, and cognitive impairment |
| abstract |
Certain aspects of the invention provide that two or more active agents (eg, may be used to treat menopause, mood disorders, anxiety disorders, or cognitive disorders) when administered together. The present invention relates to a pharmaceutical composition comprising The first component of the pharmaceutical composition is the sedative eszopiclone. The second component of the pharmaceutical composition is trans 4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine or trans 4- (3,4- Dichlorophenyl) -1,2,3,4-tetrahydro-1-naphthalenamine. The invention further relates to methods for treating menopause, perimenopause, mood disorders, anxiety disorders, and cognitive disorders. |